• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一种新型移植模型中,载脂蛋白E缺陷小鼠晚期动脉粥样硬化斑块的显著重塑。

Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.

作者信息

Reis E D, Li J, Fayad Z A, Rong J X, Hansoty D, Aguinaldo J G, Fallon J T, Fisher E A

机构信息

Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

出版信息

J Vasc Surg. 2001 Sep;34(3):541-7. doi: 10.1067/mva.2001.115963.

DOI:10.1067/mva.2001.115963
PMID:11533609
Abstract

OBJECTIVE

Regression of atherosclerotic lesions is an important goal. No extensive experimental evidence shows that it can be achieved for advanced lesions. To study this, we developed a model to maintain a long-term change in the plasma lipoprotein environment of advanced arterial lesions of hyperlipidemic (apolipoprotein E [apoE]-deficient) mice.

METHODS

The apoE-deficient mice (plasma total cholesterol of 1334 +/- 219 [+/- SEM] mg/dL) on a typical Western diet for 38 weeks had advanced atherosclerotic lesions (ie, beyond the macrophage foam cell stage) throughout the arterial tree. Lesion-containing thoracic aortas were transplanted (replacing a segment of abdominal aorta) into either apoE-deficient or wild-type (WT) (total cholesterol of 86 +/- 10 mg/dL) recipients. Grafts were harvested after 9 weeks.

RESULTS

Compared with pretransplant lesions (area = 0.0892 +/- 0.0179 mm(2)), lesion size tended to increase in apoE-deficient to apoE-deficient grafts (0.2411 +/- 0.0636 mm(2); P =.06), whereas a significant reduction was seen in apoE-deficient to WT grafts (0.0214 +/- 0.0049 mm(2); P <.001). Also, foam cells were absent in apoE-deficient to WT grafts, but abundant in pretransplant lesions and apoE-deficient to apoE-deficient grafts. Grafts were evaluated noninvasively in vivo with magnetic resonance imaging, and wall thickening was detected in the apoE-deficient to apoE-deficient group.

CONCLUSIONS

Nearly complete regression of advanced atherosclerotic lesions can be achieved with sustained normalization of the plasma lipoprotein profile. Syngeneic arterial transplantation in mice is a novel and valuable model system for atherosclerosis research; and magnetic resonance imaging can detect differences in characteristics in lesions undergoing regression.

摘要

目的

动脉粥样硬化病变的消退是一个重要目标。尚无广泛的实验证据表明晚期病变能够实现消退。为研究这一问题,我们建立了一个模型,以维持高脂血症(载脂蛋白E [apoE] 缺陷)小鼠晚期动脉病变血浆脂蛋白环境的长期变化。

方法

在典型西方饮食喂养38周后,apoE缺陷小鼠(血浆总胆固醇为1334±219 [±SEM] mg/dL)在整个动脉树中出现了晚期动脉粥样硬化病变(即超过巨噬细胞泡沫细胞阶段)。将含有病变的胸主动脉移植(替换腹主动脉的一段)到apoE缺陷或野生型(WT)(总胆固醇为86±10 mg/dL)受体小鼠体内。9周后收获移植血管。

结果

与移植前病变(面积 = 0.0892±0.0179 mm²)相比,apoE缺陷小鼠到apoE缺陷小鼠的移植血管病变大小有增加趋势(0.2411±0.0636 mm²;P = 0.06),而apoE缺陷小鼠到WT小鼠的移植血管病变则显著减小(0.0214±0.0049 mm²;P < 0.001)。此外,apoE缺陷小鼠到WT小鼠的移植血管中没有泡沫细胞,但在移植前病变以及apoE缺陷小鼠到apoE缺陷小鼠的移植血管中泡沫细胞丰富。通过磁共振成像对移植血管进行体内无创评估,在apoE缺陷小鼠到apoE缺陷小鼠组中检测到血管壁增厚。

结论

血浆脂蛋白谱持续正常化可使晚期动脉粥样硬化病变几乎完全消退。小鼠同基因动脉移植是一种用于动脉粥样硬化研究的新型且有价值的模型系统;磁共振成像可检测正在消退的病变特征差异。

相似文献

1
Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.在一种新型移植模型中,载脂蛋白E缺陷小鼠晚期动脉粥样硬化斑块的显著重塑。
J Vasc Surg. 2001 Sep;34(3):541-7. doi: 10.1067/mva.2001.115963.
2
Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.通过体内磁共振成像对小鼠动脉粥样硬化进行的系列研究发现,血脂异常得到纠正后病变会消退。
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1714-9. doi: 10.1161/01.ATV.0000139313.69015.1c. Epub 2004 Jul 15.
3
Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility.不同动脉粥样硬化易感性的载脂蛋白E缺陷小鼠品系中的循环黏附分子
Biochem Biophys Res Commun. 2005 Apr 15;329(3):1102-7. doi: 10.1016/j.bbrc.2005.02.090.
4
Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.巨噬细胞源性载脂蛋白E对低密度脂蛋白受体缺陷小鼠高脂血症和动脉粥样硬化的影响。
Biochem Biophys Res Commun. 2004 Apr 23;317(1):223-9. doi: 10.1016/j.bbrc.2004.03.037.
5
Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.长期给予3-去氮腺苷不会改变载脂蛋白E缺乏小鼠晚期动脉粥样硬化病变的进展。
J Cardiovasc Pharmacol. 2007 Aug;50(2):206-12. doi: 10.1097/FJC.0b013e318070c66a.
6
Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice.遗传背景而非动脉粥样硬化病变的大小决定了载脂蛋白E缺陷小鼠主动脉根部的中膜破坏。
Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1901-6. doi: 10.1161/01.ATV.0000091249.34404.B7. Epub 2003 Aug 14.
7
High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.高密度脂蛋白可延缓动脉粥样硬化的进展,并能在不抑制炎症或氧化指标的情况下,使病变得到良好重塑。
Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1904-9. doi: 10.1161/01.ATV.0000142808.34602.25. Epub 2004 Aug 19.
8
Involvement of the nitric oxide system in the anti-atherosclerotic potential of lacidipine in the ApoE-deficient mouse: a morphological, functional, and electrochemical study.一氧化氮系统在拉西地平对载脂蛋白E缺陷小鼠抗动脉粥样硬化潜能中的作用:一项形态学、功能学及电化学研究
Toxicol Pathol. 2004 Jul-Aug;32(4):493-9. doi: 10.1080/01926230490483351.
9
Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.巨噬细胞源性载脂蛋白E改善肥胖载脂蛋白E缺陷小鼠的血脂异常和动脉粥样硬化。
Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E284-90. doi: 10.1152/ajpendo.00601.2007. Epub 2007 Nov 20.
10
Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.骨髓源性晚期糖基化终产物受体缺失抑制动脉粥样硬化斑块进展。
Eur J Clin Invest. 2011 Nov;41(11):1164-71. doi: 10.1111/j.1365-2362.2011.02514.x. Epub 2011 Mar 21.

引用本文的文献

1
Nanoparticle-based itaconate treatment recapitulates low-cholesterol/low-fat diet-induced atherosclerotic plaque resolution.基于纳米颗粒的衣康酸盐疗法再现了低胆固醇/低脂饮食诱导的动脉粥样硬化斑块消退。
Cell Rep. 2024 Nov 26;43(11):114911. doi: 10.1016/j.celrep.2024.114911. Epub 2024 Oct 28.
2
Diagnostics of atherosclerosis: Overview of the existing methods.动脉粥样硬化的诊断:现有方法概述。
Front Cardiovasc Med. 2023 May 9;10:1134097. doi: 10.3389/fcvm.2023.1134097. eCollection 2023.
3
Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in Mice.
巨噬细胞特异性糖原合酶激酶(GSK)-3α缺失促进小鼠动脉粥样硬化消退。
Int J Mol Sci. 2022 Aug 18;23(16):9293. doi: 10.3390/ijms23169293.
4
Trafficking of Mononuclear Phagocytes in Healthy Arteries and Atherosclerosis.单核吞噬细胞在健康动脉和动脉粥样硬化中的运输。
Front Immunol. 2021 Oct 25;12:718432. doi: 10.3389/fimmu.2021.718432. eCollection 2021.
5
Anti-Atherogenic Effect of 10% Supplementation of Anchovy () Waste Protein Hydrolysates in ApoE-Deficient Mice.在载脂蛋白E缺陷小鼠中补充10%的鳀鱼废弃物蛋白水解物的抗动脉粥样硬化作用。
Nutrients. 2021 Jun 22;13(7):2137. doi: 10.3390/nu13072137.
6
Inducible phospholipid transfer protein deficiency ameliorates atherosclerosis.可诱导型磷脂转移蛋白缺乏可改善动脉粥样硬化。
Atherosclerosis. 2021 May;324:9-17. doi: 10.1016/j.atherosclerosis.2021.03.011. Epub 2021 Mar 13.
7
Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.高脂血症小鼠的动脉粥样硬化消退和胆固醇外排。
Circ Res. 2021 Mar 19;128(6):690-705. doi: 10.1161/CIRCRESAHA.120.317458. Epub 2021 Feb 3.
8
RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism.RAGE 损害了小鼠糖尿病动脉粥样硬化的消退,并表明 IRF7 参与了巨噬细胞炎症和胆固醇代谢。
JCI Insight. 2020 Jul 9;5(13):137289. doi: 10.1172/jci.insight.137289.
9
Atherosclerosis: Making a U Turn.动脉粥样硬化:U 型转弯。
Annu Rev Med. 2020 Jan 27;71:191-201. doi: 10.1146/annurev-med-042418-011108.
10
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice.恩格列净通过 SGLT2 抑制剂降低血糖可加速高血糖链脲佐菌素糖尿病小鼠的动脉粥样硬化消退。
Sci Rep. 2019 Nov 29;9(1):17937. doi: 10.1038/s41598-019-54224-9.